VCEL insider trading
NasdaqGM HealthcareVericel Corp — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About Vericel Corp
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. and changed its name to Vericel Corporation in November 2014. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.
Company website: www.vcel.com
VCEL insider activity at a glance
FilingIQ has scored 736 insider transactions for VCEL since Mar 20, 2015. The most recent filing in our index is dated May 11, 2026.
Across the full history, 3 open-market purchases
and 206 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on VCEL insider trades is 64.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest VCEL Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for VCEL?
- FilingIQ tracks 736 Form 4 insider transactions for VCEL (Vericel Corp), covering filings from Mar 20, 2015 onwards. 127 of those were filed in the last 90 days.
- Are VCEL insiders net buyers or net sellers?
- Across the full Form 4 history for VCEL, 3 transactions (0%) were open-market purchases and 206 (28%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does VCEL insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is VCEL in?
- Vericel Corp (VCEL) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.94B.
Methodology & sources
Every VCEL insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.